{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:38:49Z","timestamp":1787164729391,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40122-021-00313-5","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T03:02:41Z","timestamp":1630724561000},"page":"1003-1012","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pharmacological Advances in Opioid Therapy: A Review of the Role of Oliceridine in Pain Management"],"prefix":"10.1007","volume":"10","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber N.","family":"Edinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C.","family":"Babin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chance M.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Hardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse M.","family":"Cornett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"issue":"1","key":"313_CR1","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1503\/cmaj.109-5523","volume":"190","author":"R Collier","year":"2018","unstructured":"Collier R. A short history of pain management. CMAJ Can Med Assoc J. 2018;190(1):E26\u20137.","journal-title":"CMAJ Can Med Assoc J"},{"key":"313_CR2","unstructured":"Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy\u2014PubMed [Internet]. https:\/\/portal.lsuhs.edu\/https\/pubmed.ncbi.nlm.nih.gov\/3461421\/. Cited 18 Feb 2021."},{"key":"313_CR3","unstructured":"Mr C, Gj T. Neurobiology of pain [Internet]. Vol. 25, Advances in psychosomatic medicine. Adv Psychosom Med; 2004. https:\/\/pubmed.ncbi.nlm.nih.gov\/15248368\/. Cited 18 Feb 2021."},{"key":"313_CR4","unstructured":"M C, J S, Cj W. Neuropathic pain: a maladaptive response of the nervous system to damage [Internet]. Vol. 32, Annual review of neuroscience. Annu Rev Neurosci; 2009. https:\/\/pubmed.ncbi.nlm.nih.gov\/19400724\/. Cited 18 Feb 2021."},{"key":"313_CR5","unstructured":"Descending pain modulation and chronification of pain - PubMed [Internet]. https:\/\/portal.lsuhs.edu\/https\/pubmed.ncbi.nlm.nih.gov\/24752199\/. Cited 18 Feb 2021."},{"key":"313_CR6","unstructured":"Dj G, P R. The economic costs of pain in the United States [Internet]. Vol. 13, The journal of pain. J Pain; 2012. https:\/\/pubmed.ncbi.nlm.nih.gov\/22607834\/. Cited 18 Feb 2021."},{"issue":"2","key":"313_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/AIA.0000000000000275","volume":"58","author":"S Boyaji","year":"2020","unstructured":"Boyaji S, Pukenas EW, Urman RD. The opioid epidemic and how anesthesiologists can help. Int Anesthesiol Clin. 2020;58(2):28\u201333.","journal-title":"Int Anesthesiol Clin"},{"issue":"5","key":"313_CR8","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/ahr\/120.5.1920","volume":"120","author":"L Umansky","year":"2015","unstructured":"Umansky L. Keith Wailoo. Pain: a political history. Am Hist Rev. 2015;120(5):1920\u20131.","journal-title":"Am Hist Rev"},{"key":"313_CR9","unstructured":"Mr J, O V, J P, Ad K, Js G, Tt S. A Brief History of the Opioid Epidemic and Strategies for Pain Medicine [Internet]. Vol. 7, Pain and therapy. Pain Ther; 2018. https:\/\/pubmed.ncbi.nlm.nih.gov\/29691801\/. Cited 18 Feb 2021."},{"key":"313_CR10","doi-asserted-by":"crossref","unstructured":"Sh R, Rm F, Fx B, F D, B B, Rj R, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation [Internet]. Vol. 160, Archives of internal medicine. Arch Intern Med; 2000. https:\/\/pubmed.ncbi.nlm.nih.gov\/10737286\/. Cited 18 Feb 2021.","DOI":"10.1001\/archinte.160.6.853"},{"key":"313_CR11","doi-asserted-by":"crossref","unstructured":"Ra M, F W-C, D O, L M, Sm A, L G. Measuring pain as the 5th vital sign does not improve quality of pain management [Internet]. Vol. 21, Journal of general internal medicine. J Gen Intern Med; 2006. https:\/\/pubmed.ncbi.nlm.nih.gov\/16808744\/. Cited 18 Feb 2021.","DOI":"10.1111\/j.1525-1497.2006.00415.x"},{"key":"313_CR12","unstructured":"Core aspects of satisfaction with pain management: cancer patients\u2019 perspectives - PubMed [Internet]. https:\/\/portal.lsuhs.edu\/https\/pubmed.ncbi.nlm.nih.gov\/19879107\/. Cited 18 Feb 2021."},{"issue":"4","key":"313_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.anclin.2018.07.014","volume":"36","author":"RA Gabriel","year":"2018","unstructured":"Gabriel RA, Burton BN, Urman RD, Waterman RS. Genomics testing and personalized medicine in the preoperative setting. Anesthesiol Clin. 2018;36(4):639\u201352.","journal-title":"Anesthesiol Clin"},{"issue":"2","key":"313_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.anclin.2017.01.015","volume":"35","author":"R Saba","year":"2017","unstructured":"Saba R, Kaye AD, Urman RD. Pharmacogenomics in pain management. Anesthesiol Clin. 2017;35(2):295\u2013304.","journal-title":"Anesthesiol Clin"},{"key":"313_CR15","first-page":"125","volume":"12","author":"AD Kaye","year":"2019","unstructured":"Kaye AD, Garcia AJ, Hall OM, Jeha GM, Cramer KD, Granier AL, et al. Update on the pharmacogenomics of pain management. Pharmacogenomics Pers Med. 2019;12:125\u201343.","journal-title":"Pharmacogenomics Pers Med"},{"issue":"2","key":"313_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11912-020-0865-4","volume":"22","author":"EM Cornett","year":"2020","unstructured":"Cornett EM, Carroll Turpin MA, Pinner A, Thakur P, Sekaran TSG, Siddaiah H, et al. Pharmacogenomics of pain management: the impact of specific biological polymorphisms on drugs and metabolism. Curr Oncol Rep. 2020;22(2):18.","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"313_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/phar.1986","volume":"37","author":"A Owusu Obeng","year":"2017","unstructured":"Owusu Obeng A, Hamadeh I, Smith M. Review of opioid pharmacogenetics and considerations for pain management. Pharmacotherapy. 2017;37(9):1105\u201321.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"313_CR18","first-page":"766","volume":"87","author":"RD Blondell","year":"2013","unstructured":"Blondell RD, Azadfard M, Wisniewski AM. Pharmacologic therapy for acute pain. Am Fam Physician. 2013;87(11):766\u201372.","journal-title":"Am Fam Physician"},{"issue":"6","key":"313_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/j.1360-0443.2010.02902.x","volume":"105","author":"J Swendsen","year":"2010","unstructured":"Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR, et al. Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addict Abingdon Engl. 2010;105(6):1117\u201328.","journal-title":"Addict Abingdon Engl"},{"issue":"4","key":"313_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/ACO.0000000000000218","volume":"28","author":"S Shah","year":"2015","unstructured":"Shah S, Kapoor S, Durkin B. Analgesic management of acute pain in the opioid-tolerant patient. Curr Opin Anaesthesiol. 2015;28(4):398\u2013402.","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"313_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.anclin.2018.09.010","volume":"37","author":"JL Gross","year":"2019","unstructured":"Gross JL, Perate AR, Elkassabany NM. Pain management in trauma in the age of the opioid crisis. Anesthesiol Clin. 2019;37(1):79\u201391.","journal-title":"Anesthesiol Clin"},{"issue":"6","key":"313_CR22","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","volume":"27","author":"O Corli","year":"2016","unstructured":"Corli O, Floriani I, Roberto A, Montanari M, Galli F, Greco MT, et al. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u201creal life\u201d trial on the variability of response to opioids. Ann Oncol. 2016;27(6):1107\u201315.","journal-title":"Ann Oncol"},{"issue":"1","key":"313_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5055\/jom.2018.0430","volume":"14","author":"M Mazer-Amirshahi","year":"2018","unstructured":"Mazer-Amirshahi M, Motov S, Nelson LS. Hydromorphone use for acute pain: Misconceptions, controversies, and risks. J Opioid Manag. 2018;14(1):61\u201371.","journal-title":"J Opioid Manag"},{"issue":"1","key":"313_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjopharm.2009.02.002","volume":"7","author":"AK Chang","year":"2009","unstructured":"Chang AK, Bijur PE, Baccelieri A, Gallagher EJ. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial. Am J Geriatr Pharmacother. 2009;7(1):1\u201310.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"11","key":"313_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/bjsports-2018-099805","volume":"54","author":"H-R Tucker","year":"2020","unstructured":"Tucker H-R, Scaff K, McCloud T, Carlomagno K, Daly K, Garcia A, et al. Harms and benefits of opioids for management of non-surgical acute and chronic low back pain: a systematic review. Br J Sports Med. 2020;54(11):664.","journal-title":"Br J Sports Med"},{"key":"313_CR26","unstructured":"Drugs@FDA: FDA-Approved Drugs [Internet]. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=210730. Cited 1 Feb 2021."},{"key":"313_CR27","unstructured":"OLINVYK (oliceridine) for the Treatment of Acute Pain, USA [Internet]. https:\/\/www.clinicaltrialsarena.com\/projects\/olinvyk-oliceridine\/. Cited 29 Jan 2021."},{"key":"313_CR28","unstructured":"admin. Oliceridine Approved for Management of Acute Pain [Internet]. ASH Clinical News. 2020. https:\/\/www.ashclinicalnews.org\/online-exclusives\/fda-approves-oliceridine-management-acute-pain\/. Cited 29 Jan 2021."},{"issue":"2","key":"313_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3344\/kjp.2018.31.2.73","volume":"31","author":"HG Ok","year":"2018","unstructured":"Ok HG, Kim SY, Lee SJ, Kim TK, Huh BK, Kim KH. Can oliceridine (TRV130), an ideal novel \u00b5 receptor G protein pathway selective (\u00b5-GPS) modulator, provide analgesia without opioid-related adverse reactions? Korean J Pain. 2018;31(2):73\u20139.","journal-title":"Korean J Pain"},{"issue":"46","key":"313_CR30","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1021\/acs.biochem.6b00948","volume":"55","author":"S Schneider","year":"2016","unstructured":"Schneider S, Provasi D, Filizola M. How oliceridine (TRV-130) binds and stabilizes a \u03bc-opioid receptor conformational state that selectively triggers g protein signaling pathways. Biochemistry. 2016;55(46):6456\u201366.","journal-title":"Biochemistry"},{"issue":"6","key":"313_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1177\/0269881116689257","volume":"31","author":"AA Altarifi","year":"2017","unstructured":"Altarifi AA, David B, Muchhala KH, Blough BE, Akbarali H, Negus SS. Effects of Acute and repeated treatment with the biased mu opioid receptor agonist trv130 (oliceridine) on measures of antinociception, gastrointestinal function & abuse liability in rodents. J Psychopharmacol Oxf Engl. 2017;31(6):730\u20139.","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"313_CR32","unstructured":"Olinvyk (Oliceridine Injection): Uses, dosage, side effects, interactions, warning [Internet]. RxList. https:\/\/www.rxlist.com\/olinvyk-drug.htm. Cited 29 Jan 2021."},{"issue":"3","key":"313_CR33","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/jcph.207","volume":"54","author":"DG Soergel","year":"2014","unstructured":"Soergel DG, Subach RA, Sadler B, Connell J, Marion AS, Cowan CL, et al. First clinical experience with TRV130: pharmacokinetics and pharmacodynamics in healthy volunteers. J Clin Pharmacol. 2014;54(3):351\u20137.","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"313_CR34","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","volume":"155","author":"DG Soergel","year":"2014","unstructured":"Soergel DG, Subach RA, Burnham N, Lark MW, James IE, Sadler BM, et al. Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers. Pain. 2014;155(9):1829\u201335.","journal-title":"Pain"},{"issue":"1","key":"313_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/j.pain.0000000000000363","volume":"157","author":"ER Viscusi","year":"2016","unstructured":"Viscusi ER, Webster L, Kuss M, Daniels S, Bolognese JA, Zuckerman S, et al. A randomized, phase 2 study investigating TRV130, a biased ligand of the \u03bc-opioid receptor, for the intravenous treatment of acute pain. Pain. 2016;157(1):264\u201372.","journal-title":"Pain"},{"issue":"7","key":"313_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/papr.12801","volume":"19","author":"NK Singla","year":"2019","unstructured":"Singla NK, Skobieranda F, Soergel DG, Salamea M, Burt DA, Demitrack MA, et al. APOLLO-2: A randomized, placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the \u03bc-opioid receptor, for management of moderate to severe acute pain following abdominoplasty. Pain Pract. 2019;19(7):715\u201331.","journal-title":"Pain Pract"},{"issue":"4","key":"313_CR37","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00216-012-5716-1","volume":"403","author":"J Acevska","year":"2012","unstructured":"Acevska J, Stefkov G, Petkovska R, Kulevanova S, Dimitrovska A. Chemometric approach for development, optimization, and validation of different chromatographic methods for separation of opium alkaloids. Anal Bioanal Chem. 2012;403(4):1117\u201329.","journal-title":"Anal Bioanal Chem"},{"issue":"5","key":"313_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1037\/a0013628","volume":"16","author":"A Rosenblum","year":"2008","unstructured":"Rosenblum A, Marsch LA, Joseph H, Portenoy RK. Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions. Exp Clin Psychopharmacol. 2008;16(5):405\u201316.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"9","key":"313_CR39","doi-asserted-by":"publisher","first-page":"e108250","DOI":"10.1371\/journal.pone.0108250","volume":"9","author":"CA Valdez","year":"2014","unstructured":"Valdez CA, Leif RN, Mayer BP. An efficient, optimized synthesis of fentanyl and related analogs. PLoS ONE. 2014;9(9):e108250.","journal-title":"PLoS ONE"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-021-00313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-021-00313-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-021-00313-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T11:50:57Z","timestamp":1636631457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-021-00313-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["313"],"URL":"https:\/\/doi.org\/10.1007\/s40122-021-00313-5","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"11 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}